Literature DB >> 22258314

The effect of weight loss in obesity and chronic kidney disease.

Enrique Morales1, Manuel Praga.   

Abstract

Several epidemiologic investigations have confirmed that obesity is a significant risk factor for the appearance of proteinuria and end-stage kidney disease in a normal population. Weight loss induced by low-calorie diets, physical exercise, or bariatric surgery is accompanied by an important antiproteinuric effect. Reduction in proteinuria is already observed after a few weeks from the onset of weight loss and it is evident even in patients with modest weight losses. Reduction in proteinuria by weight loss has been described in chronic proteinuric nephropathies of different etiologies. The mechanisms through which weight loss may reverse proteinuria are likely to be plural: better control of blood pressure, improvement of serum lipid profile, improvement of insulin sensitivity, better glycemic control in diabetes patients, decrease of circulating leptin levels, reversal of glomerular hyperfiltration, and decreased activation of the renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Year:  2012        PMID: 22258314     DOI: 10.1007/s11906-012-0247-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

Review 1.  Aldosterone in chronic kidney and cardiac disease.

Authors:  Thomas H Hostetter; Hassan N Ibrahim
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

2.  Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney.

Authors:  Ester González; Eduardo Gutiérrez; Enrique Morales; Eduardo Hernández; Amado Andres; Ignacio Bello; Rafael Díaz-González; Oscar Leiva; Manuel Praga
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

Review 3.  The many masks of focal segmental glomerulosclerosis.

Authors:  V D'Agati
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

4.  Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.

Authors:  M Praga; E Hernández; E Morales; A P Campos; M A Valero; M A Martínez; M León
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

Review 5.  Abnormal kidney function as a cause and a consequence of obesity hypertension.

Authors:  J E Hall; M W Brands; J R Henegar; E W Shek
Journal:  Clin Exp Pharmacol Physiol       Date:  1998-01       Impact factor: 2.557

Review 6.  The relationship between hyperinsulinemia, hypertension and progressive renal disease.

Authors:  Fadi A El-Atat; Sameer N Stas; Samy I McFarlane; James R Sowers
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

7.  Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].

Authors:  G Wolf; A Hamann; D C Han; U Helmchen; F Thaiss; F N Ziyadeh; R A Stahl
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

Review 8.  Scope and mechanisms of obesity-related renal disease.

Authors:  Tracy E Hunley; Li-Jun Ma; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

9.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  [The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].

Authors:  E Morales; A Huerta; E Gutiérrez; E Gutiérrez Solís; J Segura; M Praga
Journal:  Nefrologia       Date:  2009       Impact factor: 2.033

View more
  11 in total

Review 1.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

2.  Kidney Disease: Personalized Lifestyle Health Care Makes a Big Difference.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-12

Review 3.  On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.

Authors:  Cem Tanriover; Duygu Ucku; Carlo Basile; Katherine R Tuttle; Mehmet Kanbay
Journal:  J Nephrol       Date:  2022-07-11       Impact factor: 4.393

4.  Long-term impact of bariatric surgery in diabetic nephropathy.

Authors:  LeAnne Young; Zubaidah Nor Hanipah; Stacy A Brethauer; Philip R Schauer; Ali Aminian
Journal:  Surg Endosc       Date:  2018-09-24       Impact factor: 4.584

5.  Effects of RNA interference-mediated gene silencing of VEGF on the ultrafiltration failure in a rat model of peritoneal dialysis.

Authors:  Zhi-Kui Wang; Zhao-Xia Wang; Zhen-Ying Liu; Yue-Qin Ren; Zhong-Qi Zhou
Journal:  Biosci Rep       Date:  2017-08-30       Impact factor: 3.840

6.  KI Reports and World Kidney Day.

Authors:  Jai Radhakrishnan; Sumit Mohan
Journal:  Kidney Int Rep       Date:  2017-02-03

Review 7.  [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]

Authors:  V Pallarés Carratalá; C Górriz-Zambrano; C Morillas Ariño; J L Llisterri Caro; J L Gorriz
Journal:  Semergen       Date:  2020-05-11

8.  Foods contributing to nutrients intake and assessment of nutritional status in pre-dialysis patients: a cross-sectional study.

Authors:  Yeon Kyung Seo; Hyesu Lee; Hyunsuk Kim; Tae Yeon Kim; Hyunjin Ryu; Dal Lae Ju; Miyoung Jang; Kook-Hwan Oh; Curie Ahn; Sung Nim Han
Journal:  BMC Nephrol       Date:  2020-07-25       Impact factor: 2.388

9.  Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cortney Steele; Kristen Nowak
Journal:  Kidney Dial       Date:  2022-03-04

Review 10.  GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists.

Authors:  José Luis Górriz; María José Soler; Juan F Navarro-González; Clara García-Carro; María Jesús Puchades; Luis D'Marco; Alberto Martínez Castelao; Beatriz Fernández-Fernández; Alberto Ortiz; Carmen Górriz-Zambrano; Jorge Navarro-Pérez; Juan José Gorgojo-Martinez
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.